Down-regulation of normal human T cell blast activation: Roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression

Journal of Leukocyte Biology

Volumn 77, Issue 4, 2005, Pages 568-578

  Bosque, Alberto ^a   Pardo, Julián ^a   Martínez Lorenzo, Ma José ^b   Iturralde, Maria ^a   Marzo, Isabel ^a   Piñeiro, Andrés ^a   Alava, Ma Angeles ^a   Naval, Javier ^a   Anel, Alberto ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Apoptosis; Growth arrest; T lymphocytes

Indexed keywords

BIM PROTEIN; CD3 ANTIGEN; CD59 ANTIGEN; CYCLOHEXIMIDE; FAS LIGAND; FLICE INHIBITORY PROTEIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ; PROTEIN BCL X; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; T LYMPHOBLAST; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DEATH; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16844375891     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0904514     Document Type: Article

References (49)

1. + thymocytes. Nature 333, 742-746.
2. Van Parijs, L., Abbas, A. K. (1998) Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248.
3. Schwartz, R. H. (1990) A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
4. Steinman, R. M., Turley, S., Mellman, I., Inaba, K. (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416.
5. Sakaguchi, S. (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455-458.
6. Krummel, M. F., Allison, J. P. (1996) CTLA-4 engagement inhibits IL2 accumulation and cell cycle progression of resting T cells. J. Exp. Med. 183, 2533-2540.
7. + T cell selection, function, and death in the primary immune response in vivo. J. Clin. Invest. 106, 1251-1261.
8. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Kappler, J., Marrack, P. (2002) Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14, 354-359.
9. Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Königen, F., Adams, J. M., Strasser, A. (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738.
10. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J., Marrack, P. (2002) Activated T cell death in vivo mediated by proapototic Bcl-2 family member Bim. Immunity 16, 759-767.
11. Dhein, J., Walczak, H., Bäumler, C., Debatin, K. M., Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373, 438-441.
12. Vignaux, F., Golstein, P. (1994) Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24, 923-927.
13. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-979.
14. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Nagata, S. (1992) Lymphoproliferation disorder explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
15. Rieux-Laucat, F., Le Deist, F., Fischer, A. (2003) Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 10, 124-133.
16. Martínez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, J. K., Chuntharapai, A., Piñeiro, A., Naval, J., Anel, A. (1998) Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28, 2714-2725.
17. -/- mice. Nat. Immunol. 4, 255-260.
18. Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J., Marrack, P. C. (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10, 735-744.
19. Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., Piñeiro, A., Larrad, L., Alava, M. A., Naval, J., Anel, A. (2001) Differential secretion of Fas ligand- or APO2 ligand/TRAIL-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167, 6736-6744.
20. Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., Piñeiro, A., Alava, M. A., Naval, J. (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163, 1274-1281.
21. Monleón, I., Martínez-Lorenzo, M. J., Anel, A., Lasierra, P., Larrad, L., Piñeiro, A., Naval, J., Alava, M. A. (2000) CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells. Eur. J. Immunol. 30, 1078-1087.
22. Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K. M., Krammer, P. H. (1997) Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signalling complex. Eur. J. Immunol. 27, 1207-1212.
23. Irmler, M., Thome, M., Halme, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schröter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature. 388, 190-195.
24. Algeciras-Schimnich, A., Griffith, T. S., Lynch, D. H., Paya, C. V. (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162, 5205-5211.
25. Scaffidi, C., Schmitz, I., Krammer, P. H., Peter, M. E. (1999) The role of c-FLIP in modulation of CD95-mediated apoptosis. J. Biol. Chem. 274, 1541-1548.
26. Bin, L., Li, X., Xu, L. G., Shu, H. B. (2002) The short splice form of casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis. FEBS Lett. 510, 37-40.
27. short correlates with resistance toward CD95-mediated apoptosis by blocking Dros Inf ServC activity. J. Immunol. 165, 6293-6300.
28. Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H., Kirchhoff, S. (2001) c-FLIP splice variants inhibit different steps of caspase-8 activation at the CD95 Dros Inf ServC. J. Biol. Chem. 276, 20633-20640.
29. Schmitz, I., Krueger, A., Baumann, S., Schulze-Bergkamen, H., Krammer, P. H., Kirchhoff, S. (2003) An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated AICD. J. Immunol. 171, 2930-2936.
30. Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Ashkenazi, A. (2001) Differential hepatocyte toxicity of recombinant APO2L/TRAIL versions. Nat. Med. 7, 383-385.
31. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
32. Martínez-Lorenzo, M. J., Alava, M. A., Anel, A., Piñeiro, A., Naval, J. (1996) Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89, 511-517.
33. Alava, M. A., DeBell, K. E., Conti, A., Hoffman, T., Bonvini, E. (1992) Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A phosphorylation of phospholipase C-γ. Biochem. J. 284, 189-199.
34. Ohla, K., Iwai, K., Kasahara, Y., Taniguchi, N., Krajewski, S., Reed, J. C., Miyawaki, T. (1995) Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int. Immunol. 7, 1817-1825.
35. Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., Thompson, C. B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
36. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., Lynch, D. H. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235.
37. Kreuz, S., Siegmund, D., Scheurich, P., Wajant, H. (2001) NF-κB upregulates cFLlP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21, 3964-3973.
38. Pellegrini, M., Belz, G., Bouillet, P., Strasser, A. (2003) Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic BH3-only protein Bim. Proc. Natl. Acad. Sci. USA 100, 14175-14180.
39. Sandalova, E., Wei, C. H., Masucci, M. G., Levitsky, V. (2004) Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc. Natl. Acad. Sci. USA 101, 3011-3016.
40. Schmitz, I., Weyd, H., Krueger, A., Baumann, S., Fas, S. C., Krammer, P. H., Kirchhoff, S. (2004) Resistance of short-term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J. Immunol. 172, 2194-2200.
41. Hieronymus, T., Blank, N., Gruenke, M., Winkler, S., Haas, J. P., Kalden, J. R., Lorenz, H. M. (2000) CD95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death Differ. 7, 538-547.
42. Hilliard, B., Wilmen, A., Seidel, C., Liu, T. S. T., Göke, R., Chen, Y. (2001) Roles of TRAIL in experimental autoimmune encephalomyelitis. J. Immunol. 166, 1314-1319.
43. Lüneniann, J. D., Waiczies, S., Ehrlich, S., Wendling, U., Seeger, B., Kamradt, T., Zipp, F. (2002) Death ligand TRAIL induces no apoptosis but inhibits activation of human autoantigen-specific T cells. J. Immunol. 168, 4881-4888.
44. Song, K., Chen, Y., Göke, R., Wilmen, A., Seidel, C., Göke, A., Hilliard, B., Chen, Y. (2000) TRAIL is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191, 1095-1103.
45. Muppidi, J. R., Siegel, R. M. (2004) Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5, 182-189.
46. Sprent, J., Tough, D. F. (2001) T cell death and memory. Science 293, 245-248.
47. + T cells. J. Immunol. 164, 3950-3954.
48. Strauss, G., Knape, I., Melzner, I., Debatin, K. M. (2003) Constitutive caspase activation and impaired death-inducing complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J. Immunol. 171, 1172-1182.
49. Bessler, M., Rosti, V., Peng, Y., Cattoretti, G., Notaro, R., Ohsako, S., Elkon, K. B., Luzzatto, L. (2002) GPI-linked proteins are required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Eur. J. Immunol. 32, 2607-2616.